SCI (Stem Cell Innovations) forms pact to explore bone-forming capacity of Pluricells:
This article was originally published in Clinica
US firm Stem Cell Innovations (SCI) has linked up with the University of Twente, in Enschede, the Netherlands, to assess the bone-forming properties of its PluriCells, a type of pluripotent stem cells isolated from foetal tissue. Houston, Texas-based SCI will give the university access to its human pluripotent stem cell technology and know-how in return for a nonexclusive licence to intellectual property generated with the PluriCells. PluriCells are developed from foetal germ cells rather than viable embryos and are, therefore, excluded from the US 2002 ban on federally funded stem cell research.